share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股SEC公告 ·  07/11 01:04
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 07/10/2024, with an aggregate market value of $374,000. These shares were originally acquired on 09/01/2016 as founders shares and were part of Gibson's compensation from the issuer. This planned sale follows a recent history of transactions where a total of 200,000 shares were sold over the past three months, generating gross proceeds of $1,681,000.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 07/10/2024, with an aggregate market value of $374,000. These shares were originally acquired on 09/01/2016 as founders shares and were part of Gibson's compensation from the issuer. This planned sale follows a recent history of transactions where a total of 200,000 shares were sold over the past three months, generating gross proceeds of $1,681,000.
Recursion Pharmaceuticals，Inc.的高管和董事Christopher Gibson計劃於07/10/2024出售50,000股A類股票，市值合計374,000美元。這些股票最初是在09/01/2016作爲創始股份獲得的，是Gibson從發行人獲得的報酬的一部分。在過去的三個月中，有共計200,000股股票被出售，總收益爲1,681,000美元。
Recursion Pharmaceuticals，Inc.的高管和董事Christopher Gibson計劃於07/10/2024出售50,000股A類股票，市值合計374,000美元。這些股票最初是在09/01/2016作爲創始股份獲得的，是Gibson從發行人獲得的報酬的一部分。在過去的三個月中，有共計200,000股股票被出售，總收益爲1,681,000美元。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。